Vickey Taylor
Family · Phoenix, AZNPI 1538723465
Payments from drug & device makers
Across 96 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$393
- Abbott$200
- Boston Scientific$138
- Collegium Pharmaceutical, Inc.$133
- Lilly USA, LLC$131
- Gilead$114
- plus $656 from 17 others
What the payments were for
- Food & beverage$1,765100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 26 | $393 |
| Abbott | 9 | $200 |
| Boston Scientific | 5 | $138 |
| Collegium Pharmaceutical, Inc. | 8 | $133 |
| Lilly USA, LLC | 9 | $131 |
| Gilead | 6 | $114 |
| Vertex | 4 | $103 |
| Amgen | 5 | $88 |
| Novartis | 4 | $83 |
| Lucid Diagnostics Inc. | 2 | $65 |
| Medtronic | 2 | $49 |
| Bayer | 2 | $36 |
| GSK | 2 | $30 |
| International Rehabilitative Sciences, Inc | 2 | $29 |
| AstraZeneca | 2 | $26 |
| Avanos Medical | 1 | $25 |
| Fidia Pharma USA Inc. | 1 | $25 |
| Ferring Pharmaceuticals Inc. | 1 | $22 |
| Impel Pharmaceuticals Inc. | 1 | $18 |
| Bioventus LLC | 1 | $17 |
| Pfizer | 1 | $14 |
| Novo Nordisk | 1 | $13 |
| Teleflex LLC | 1 | $12 |
How this compares
$1,765 in reported general payments places this provider in the 80th percentile of 4,119 family providers in Arizona.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 554 | $15,513 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 393 | $10,533 |
| OxycontinOxycodone Hcl | 17 | $7,029 |
| Buprenorphine | 17 | $5,021 |
| Gabapentin | 278 | $5,010 |
| BelbucaBuprenorphine Hcl | 13 | $4,535 |
| Pregabalin | 183 | $2,744 |
| Oxycodone Hcl | 147 | $2,114 |
| Lidocaine | 12 | $2,111 |
| Tramadol Hcl | 191 | $1,929 |
| Morphine Sulfate ErMorphine Sulfate | 97 | $1,679 |
| Celecoxib | 48 | $1,125 |
| Baclofen | 72 | $1,059 |
| Tizanidine Hcl | 105 | $1,014 |
| Duloxetine Hcl | 46 | $950 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Belbuca | $133 | $4,53513 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 4,119 family providers in Arizona.
Other family in Phoenix
- Kimberly HallaPhoenix$332K
- Audrey StevensonPhoenix$83K
- Rebekah EdwardsPhoenix$51K
- Tirsa QuartulloPhoenix$31K
- Jessica AcostaPhoenix$30K
- Stephanie JohnstonPhoenix$25K
- Kelly MarcelloPhoenix$23K
- Judith BergmanPhoenix$22K
- Lauren BonnerPhoenix$22K
- Rita GonzalezPhoenix$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.